Comparison of the Results of Two Therapeutic Methods: Imipramine with Combination of Imipramine and Oxybutynin in Uncomplicated Nocturnal Enuresis in 6-12 Year Old Children

Author(s):
Abstract:
Background
Imipramine is one of the common drugs therapies in enuretic children which is effective 50-60% on average. The main purpose of this research was to investigate the therapeutic effect of the combination of imipramine and oxybutynin compared to imipramine alone in uncomplicated nocturnal enuretic children.
Materials And Methods
This clinical trial study was carried out on 80 primary school children (6-12 years old) with uncomplicated enuresis that were selected among 2500 school children with screening by questionnaire. The children were randomly divided into two groups (40 in each group). One group was treated with Imipramine in combination with Oxybutynin and the other group was treated with Imipramine and placebo for a period of 3 months. After the treatment period, the treated and untreated children were determined.
Results
The frequency of cured with Imipramine and Oxybutynin therapy was 95%, and with Imipramine and placebo was 60% therefore there was a significant difference between the two therapeutic methods, clinically and statistically (P=0.00017).
Conclusion
The Result of this study showed that Imipramine and Oxybutynin treatment was more effective than Imipramine alone, although we recommend further studies to determine the rate of relapses and side effects of the above methods.
Language:
Persian
Published:
Journal of Rafsanjan University Of Medical Sciences, Volume:3 Issue: 2, 2004
Page:
113
magiran.com/p238900  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!